Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute?Coronary Syndrome.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute?Coronary Syndrome.
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute?Coronary Syndrome. J Am Coll Cardiol. 2020 01 21; 75(2):133-144.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Adult
Aged
Antibodies, Monoclonal, Humanized
Cardiovascular Diseases
Cholesterol, LDL
Female
Humans
Lipoprotein(a)
Male
Middle Aged
Risk Factors
Treatment Outcome
authors with profiles
Robert Harrington